Matches in Wikidata for { <http://www.wikidata.org/entity/Q93048106> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q93048106 description "2019 թվականի ապրիլի 11-ին հրատարակված գիտական հոդված" @default.
- Q93048106 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q93048106 description "scientific article published on 11 April 2019" @default.
- Q93048106 description "wetenschappelijk artikel" @default.
- Q93048106 description "наукова стаття, опублікована 11 квітня 2019" @default.
- Q93048106 name "Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1)" @default.
- Q93048106 name "Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1)" @default.
- Q93048106 type Item @default.
- Q93048106 label "Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1)" @default.
- Q93048106 label "Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1)" @default.
- Q93048106 prefLabel "Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1)" @default.
- Q93048106 prefLabel "Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1)" @default.
- Q93048106 P1433 Q93048106-469A2186-856E-4560-BD2D-CA17A5B675B9 @default.
- Q93048106 P1476 Q93048106-CF2468E5-47FC-43AD-BA06-C305843E95A7 @default.
- Q93048106 P2093 Q93048106-160C26DC-E67C-46F5-93E2-119F481BD32A @default.
- Q93048106 P2093 Q93048106-26F1929D-79E9-417F-A088-49DBA6FEE340 @default.
- Q93048106 P2093 Q93048106-2D977F39-EFD0-4AAB-9FF8-B43671B1ECBA @default.
- Q93048106 P2093 Q93048106-49A3A918-A194-4121-92E4-97E8EECEC16A @default.
- Q93048106 P2093 Q93048106-78944083-5B5B-458C-A0E0-55ED670A4D6E @default.
- Q93048106 P2093 Q93048106-A07B20ED-82DA-41E3-AB71-BC86B1A19182 @default.
- Q93048106 P2093 Q93048106-F7564927-BEF9-44A3-82EE-D6F505EF0B7F @default.
- Q93048106 P304 Q93048106-DE7C2EAB-273B-4738-9042-AACB78A367F0 @default.
- Q93048106 P31 Q93048106-5105F793-432C-4EA2-9738-0FBED2681E25 @default.
- Q93048106 P356 Q93048106-DA6D6E88-CAC3-4547-9716-1E48A62954B7 @default.
- Q93048106 P433 Q93048106-0AFFF914-1809-4601-BA85-6F05D4B326AB @default.
- Q93048106 P478 Q93048106-67BFEC54-8C90-448F-8223-C52881D44A07 @default.
- Q93048106 P50 Q93048106-F4551FD8-10E5-4152-8BFD-010ABF6CF9AC @default.
- Q93048106 P577 Q93048106-A9BFFE69-261C-40DA-A45F-D79B436C079C @default.
- Q93048106 P698 Q93048106-78F91FB1-6EDB-4C98-A5CB-BD7A184F2839 @default.
- Q93048106 P921 Q93048106-036541C3-969F-43E5-9712-ADF406CA69AF @default.
- Q93048106 P356 S10549-018-05081-Z @default.
- Q93048106 P698 30977027 @default.
- Q93048106 P1433 Q326085 @default.
- Q93048106 P1476 "Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1)" @default.
- Q93048106 P2093 "Akshara S Raghavendra" @default.
- Q93048106 P2093 "Carlos H Barcenas" @default.
- Q93048106 P2093 "Debu Tripathy" @default.
- Q93048106 P2093 "Kenneth R Hess" @default.
- Q93048106 P2093 "Luis Baez-Vallecillo" @default.
- Q93048106 P2093 "Stacy L Moulder" @default.
- Q93048106 P2093 "Vicente Valero" @default.
- Q93048106 P304 "227-234" @default.
- Q93048106 P31 Q13442814 @default.
- Q93048106 P356 "10.1007/S10549-018-05081-Z" @default.
- Q93048106 P433 "1" @default.
- Q93048106 P478 "176" @default.
- Q93048106 P50 Q89766270 @default.
- Q93048106 P577 "2019-04-11T00:00:00Z" @default.
- Q93048106 P698 "30977027" @default.
- Q93048106 P921 Q412616 @default.